The congressional bipartisan commitment to tame U.S. drug prices is being put to the test Thursday when the House is scheduled to vote on a legislative package combining bipartisan bills aimed at increasing prescription drug competition with definitively partisan measures intended to reinvigorate the exchange provisions of the Affordable Care Act (ACA).